REKA.TA TLV
Rekah Pharmaceutical Industry Ltd.
1W: -0.1%
1M: +12.5%
3M: +11.9%
YTD: -1.1%
1Y: -2.2%
3Y: -29.5%
5Y: -50.0%
₪1,145.00 ($3.80)
-31.00 (-2.64%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$27M
-6.4% ▼
5Y CAGR: -4.8%
Capital Expenditures
$9M
+24.3% ▲
5Y CAGR: -28.1%
Free Cash Flow
$18M
+5.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$12M
-1267.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $11M | $7M | -$2M | -$7M | $6M |
| Depreciation & Amort. | $20M | $23M | $27M | $30M | $33M |
| Stock-Based Comp. | $95K | $445K | $397K | $191K | -$136K |
| Change in Working Capital | -$20M | -$7M | $8M | $7M | $15M |
| Other Non-Cash Items | $347K | $297K | $5M | -$2M | -$27M |
| Operating Cash Flow | $11M | $21M | $39M | $28M | $27M |
| — Investing Activities — | |||||
| Capital Expenditures | -$19M | -$14M | -$7M | -$11M | -$9M |
| Acquisitions (Net) | $91K | -$22M | -$6M | -$10M | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $151K |
| Other Investing | $0 | $128K | $33K | -$223K | $24M |
| Investing Cash Flow | -$19M | -$36M | -$13M | -$21M | $15M |
| — Financing Activities — | |||||
| Net Debt Issuance | $24M | $2M | -$9M | $12M | -$45M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | -$10M | $0 | $0 |
| Other Financing | -$5M | -$5M | -$5M | -$19M | -$9M |
| Financing Cash Flow | $19M | -$3M | -$24M | -$8M | -$54M |
| Net Change in Cash | $11M | -$18M | $2M | -$898K | -$12M |
| Cash End of Period | $37M | $19M | $20M | $19M | $7M |
| Free Cash Flow | -$8M | $7M | $32M | $17M | $18M |